Antimicrobial discovery and drug development – RSC Podcast

How do we develop drugs like antibiotics? How long does it take for such a drug to go from its inception in a research lab to use in a…

World Antibiotic Awareness Week Video

This week is World Antibiotic Awareness Week.

Industry group calls for action over £500m funding gap on AMR

A life science industry report representing 36 key businesses and organisations concerned about the growing impact of anti-microbial…

Podcast: Tackling The AMR Crisis

In this podcast Mike Ward of Informa talks to Dr Peter Jackson, executive director of the AMR Centre.

Publications authored by Infex Therapeutics scientists:



  • N Ooi, V E Lee, N Chalam-Judge, R Newman, A J Wilkinson, I R Cooper, D Orr, S Lee and V J Savage. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales. Journal of Antimicrobial Chemotherapy 2021; 76(2): 460–466.




  • A J Wilkinson, N Ooi, J Finlayson, V E Lee, D Lyth, K S Maskew, R Newman, D Orr, K Ansell, K Birchall, P Canning, P Coombs, L Fusani, E McIver, J Pisco, P M Ireland, C Jenkins, I H Norville, S J Southern, R Cowan, G Hall, C Kettleborough, V J Savage, I R Cooper. Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitors. Bioorganic & Medicinal Chemistry Letters 2023; 90: 129331-129338.